Breast and Gynecologic Cancer Clinical Trials
Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive,... | Laboratory Biomarker Analysis, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine, Sargramostim | NCT02780401 | University of Washington | Active, not recruiting |
| Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy | Telapristone Acetate, Placebo, Laboratory Biomarker Analysis, Questionnaire Administration | NCT02314156 | Northwestern University | Active, not recruiting |
| Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial... | Imiquimod, Topical Fluorouracil | NCT03196180 | National Cancer Institute (NCI) | Active, not recruiting |
| Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to... | Afimoxifene, Laboratory Biomarker Analysis, Placebo, Tamoxifen Citrate | NCT02993159 | Northwestern University | Recruiting |
| Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer | Retinoid 9cUAB30, Therapeutic Conventional Surgery | NCT02876640 | National Cancer Institute (NCI) | Recruiting |
| Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger... | Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine | NCT02568566 | National Cancer Institute (NCI) | Active, not recruiting |
| Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients | Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine | NCT03036930 | National Cancer Institute (NCI) | Active, not recruiting |
| Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-... | Denosumab, Salpingo-Oophorectomy | NCT03382574 | National Cancer Institute (NCI) | Recruiting |
| Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery | Questionnaire Administration, Z-Endoxifen Hydrochloride, Placebo Administration | NCT03317405 | National Cancer Institute (NCI) | Active, not recruiting |
| Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk | Metformin, Placebo | NCT02028221 | University of Arizona | Active, not recruiting |